1.Factors Influencing Intention to Receive Examination of Diabetes Complications.
Yi Lin HSIEH ; Fang Hsin LEE ; Chien Liang CHEN ; Ming Fong CHANG ; Pei Hsuan HAN
Asian Nursing Research 2016;10(4):289-294
PURPOSE: The purpose of this study was to understand the situation of diabetes patients receiving examinations for diabetes complications and to explore the factors influencing their intention to receive examinations for diabetes complications. METHODS: A cross-sectional study was performed that included 251 diabetes patients who visited outpatient clinics in Southern Taiwan. A survey using a self-administered questionnaire was conducted from October 2015 to January 2016. The questionnaire included items on demographic characteristics, perceived susceptibility to diabetes complications, perceived seriousness of diabetes complications, perceived benefits of taking action to receive diabetes complication examinations, perceived barriers to taking action to receive diabetes complication examinations, and the intention to receive diabetes complication examinations. The data were analyzed using regression analysis. RESULTS: The percentage of participants who received fundus, foot, and kidney examinations was 67.7%, 61.4%, and 73.3%, respectively. Every point increase on the perceived barriers to taking action to receive diabetes complication examinations scale increased the intention to receive a foot examination in the following year by 0.91 times (p = .002), and every point increase on the perceived susceptibility to diabetes complications scale increased the intention to receive a kidney examination in the following year by 1.19 times (p = .045). CONCLUSIONS: Nurses should shoulder the responsibility to increase patients' intention to receive examination of diabetes complications. The results of this study can be used to promote nurses' care efficacy in preventing diabetes complications. They can also provide medical institutions with information to establish prevention and control policies for diabetes complications.
Ambulatory Care/utilization
;
Cross-Sectional Studies
;
Diabetic Angiopathies/nursing/*prevention & control/psychology
;
Diabetic Nephropathies/nursing/*prevention & control/psychology
;
Disease Susceptibility/psychology
;
Early Diagnosis
;
Female
;
Humans
;
Intention
;
Kidney Function Tests
;
Male
;
Middle Aged
;
Nurse-Patient Relations
;
Ophthalmoscopy
;
Patient Acceptance of Health Care/*psychology
;
Perception
;
Physical Examination/nursing/*psychology/utilization
;
Taiwan
2.The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
Carol Sheei-Meei WANG ; Kuo-Sheng CHENG ; Chia-Hung TANG ; Ming-Chyi PAI ; Pai-Lien CHEN ; Pei-Fang CHIEN
Clinical Psychopharmacology and Neuroscience 2022;20(4):701-714
Objective:
Moderate and severe behavioral and psychological symptoms of dementia (BPSD) often need medical treatment to improve symptoms. Agomelatine is a selective melatonergic (MT1/MT2) agonist that has normalizing effects on disturbed circadian rhythms and disrupted sleep−wake cycles. Its activity of 5HT-2C receptor antagonism is associated with lessening depression and anxiety and increasing slow-wave sleep. Based on past clinical records and current findings it suggests that agomelatine can improve BPSD for patients. This retrospective cohort study was designed to compare the BPSD before and after using agomelatine.
Methods:
Records of dementia cases who had ever received agomelatine treatment for BPSD in a general hospital setting during the past 2.5 years were identified and reviewed. Scores from before and after 3 months of treatment with agomelatine were collected for Neuropsychiatric Inventory (NPI), Brief Psychiatric Rating Scale (BPRS), and Clinical Global Impression (CGI) to compare and analyze the difference of psychological and behavioral symptoms pre- and post-agomelatine used.
Results:
Records of 144 cases of dementia with BPSD who had ever used agomelatine from January 2015 to June 2017 were collected. All of the 112 cases had BPRS and CGI scores, of which 75 cases had additional NPI scores. Among these 112 cases, the BPRS and CGI scores were significantly improved in all types of dementia. NPI scores indicated that the use of agomelatine alleviated obvious symptoms and decreased overall distress, especially in the depression/poor mood, anxiety, and sleepight behavior.
Conclusion
It is consistent with an effective result of agomelatine in improving BPSD.